By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Epigenomics AG 

Kleine Präsidentenstraße 1

Berlin    D-10178  Germany
Phone: 49-30-24-34-5-0 Fax: +49-30-24-34-55-55



Company News
Epigenomics AG Receives FDA Notification About Status Of Pending Approval Decision For Epi proColon 1/8/2016 11:07:33 AM
Epigenomics AG: Bondholders Resolve On Amendment Of The Terms And Conditions Of The 2013 Convertible Bonds 12/18/2015 10:54:18 AM
Epigenomics AG Appeals Recent FDA Request For Additional Information 11/30/2015 10:24:05 AM
Epigenomics AG Announces 2015 Third Quarter And Nine Month Financial Results And Reports On Operational Highlights 11/18/2015 10:12:33 AM
Epigenomics AG: Novel Panel Of Blood-Based DNA Methylation Biomarkers Shows Promising Results In The Detection Of Lung Cancer 11/9/2015 11:23:36 AM
FDA Requests Further Data For Approval Of Epigenomics AG' Blood Based Colorectal Cancer Screening Test 11/5/2015 10:19:22 AM
Epigenomics AG Adjusts 2015 Outlook After FDA Response Letter 11/4/2015 2:36:13 PM
Epigenomics AG To Provide An Update On Blood-Based Epigenetic Tests At The Association Of Molecular Pathology (AMP) 2015 Annual Meeting 11/2/2015 12:37:08 PM
Epigenomics AG Announces Q2 2015 And 6M 2015 Financial Results And Reports On Operational Highlights 8/6/2015 8:45:27 AM
Epigenomics AG And BioChain Announce The Inclusion Of their Proprietary Blood-based Septin9 Test In The Chinese Screening Guideline For Colorectal Cancer 7/15/2015 10:29:24 AM